Latest Articles about ACHN

Achillion's HCV Candidates Progress - Analyst Blog

Zacks Equity Research — Thu, 18 Apr 2013 01:12:52 Z

Achillion Pharmaceuticals, Inc. ( ACHN ) recently commenced international phase II studies on sovaprevir and ACH-3102 for the treatment of genotype 1 chronic hepatitis C (HCV). The trial

Bulls take a dose of Achillion Pharma

David Russell — Wed, 06 Mar 2013 15:45:45 Z

Our researchLAB tool flagged Achillion Pharmaceuticals as a bullish setup over the weekend, and yesterday the options agreed. An investor bought 2,000 September 10 calls for $1.60 and sold

Mid-Afternoon Market Update: Markets Near Flat; J.C. Penney Falling Further

Benzinga — Tue, 13 Nov 2012 02:04:14 Z

Towards the end of trading Monday, the Dow traded up 0.05 percent to 12,821.30 while the NASDAQ fell 0.01 percent to 2,904.54. The S&P also rose, increasing 0.04 percent to 1,380.41.

Mid-Day Market Update: Markets Slow Their Rally; JC Penney Spikes Lower

Benzinga — Mon, 12 Nov 2012 22:49:51 Z

Following the market opening Monday, the Dow traded up 0.01 percent to 12,816.12 while the NASDAQ rose 0.07 percent to 2,906.84. The S&P also rose, increasing 0.04 percent to 1,380.41.

How one trader is protecting Achillion

David Russell — Fri, 28 Sep 2012 19:34:47 Z

Achillion Pharmaceuticals has been ripping higher, and one investor wants to protect the gains. optionMONSTER's Depth Charge monitoring program detected the purchase of 3,000 October 10 puts

Achillion Pharma draws bullish bet

David Russell — Tue, 25 Sep 2012 20:34:21 Z

One investor is taking profits in Achillion Pharmaceuticals while looking for its recent rally to continue. optionMONSTER's Heat Seeker monitoring program detected the purchase of 3,000

Company News for January 25, 2012 - Corporate Summary

Zacks Equity Research — Wed, 25 Jan 2012 19:00:01 Z

• Share prices of Verizon Communication (NYSE: VZ ) fell 1.59% after its fourth-quarter earnings came in at $0.52 cents, a penny below expectations

New Top Rated Sectors - Screen of the Week

Kevin Matras — Tue, 13 Dec 2011 10:00:01 Z

Kevin Matras goes over the new top rated sectors and how to use them in your own trading. Highlighted stocks include ULTA, HXL, ASGN, AEA and ACHN. ACHILLION PHARM ( ACHN

Top Ten Undervalued Stocks With Large Cash Cushions

Kapitall — Tue, 22 Nov 2011 07:16:18 Z

( Written by Rebecca Lipman. List compiled by Eben Esterhuizen, CFA. Operating expense and cash holdings data sourced from Google Finance, EPS data sourced from Yahoo! Finance.) Analyst target

Biotech Update: Pharmasset’s Hepatitis C Drug Shows 100% Cure Rate in Ph2 Trial

Kapitall — Thu, 10 Nov 2011 06:18:06 Z

( By Alexander Crawford ) The landscape of treatment options for hepatitis C is looking brighter – biotech company Pharmasset Inc ( VRUS ) just released clinical results showing that their

Merck Reports Strong Q3 Results on Gardasil and Diabetes Med

Kapitall — Mon, 07 Nov 2011 06:19:49 Z

(Written by Alexander Crawford. Institutional data sourced from Fidelity.) At a time of significant restructuring to adapt to generic competition, Merck & Co. ( MRK ) reported an otherwise

10 Biotech Stocks Trading at Deep Discounts to Analyst Target Prices

Kapitall — Tue, 01 Nov 2011 05:18:31 Z

(Written by Alexander Crawford. Target price data sourced from Thomson/First Call (via Yahoo! Finance)) Biotech companies deal with many uncertainties, and that directly translates to

Top Performing Small Cap Stocks: July 7th (APAC, OCZ, BEBE, ACHN, HOTT)

(Wyatt Research Staff) — Fri, 08 Jul 2011 19:00:32 Z

Small cap stock indices climbed higher on Thursday, thanks to news including an acquisition and better-than-expected results from retailers and a rising star tech company. But the